SCHEMBL25232014

SCHEMBL25232014

CC(C)(C)[Si](C)(C)O[C@H]1CCN(c2ccc(S(N)(=O)=O)cc2Br)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.39
CA2 P00918 9/20 0.39
CA9 Q16790 7/20 0.39
CA7 P43166 6/20 0.39
CA12 O43570 6/20 0.39
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
VCP P55072 1/20 0.32
LIPG Q9Y5X9 2/20 0.32
POLB P06746 1/20 0.32
MCOLN3 Q8TDD5 1/20 0.32
LPL P06858 1/20 0.31
CASP3 P42574 1/20 0.31
CASP7 P55210 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30466332 1.00 CA1 (0.39) CA1CA2CA9CA7CA12
SCHEMBL25277048 1.00 CA1 (0.39) CA1CA2CA9CA7CA12
SCHEMBL25279448 0.89 HTT (0.37) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL30466277 0.89 HTT (0.37) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL25279449 0.89 HTT (0.37) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL25729174 0.79 CA12 (0.41) CA1CA2CA9CA7CA12
SCHEMBL30466283 0.78 KMT2A (0.40) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL25271933 0.78 KMT2A (0.40) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL25271934 0.78 KMT2A (0.40) ALDH1A1MAPTPOLBMCOLN3HTT
SCHEMBL25274194 0.76 NR1H2 (0.33) CA1CA2CA9CA7CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448105-A1 HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE VIR Biotechnology, Inc. (US) 2024-10-23 EP disclosed
WO-2023114428-A1 HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE Vir Biotechnology, Inc. (US) 2023-06-22 WO disclosed